Tralokinumab rapidly improves subjective symptoms and quality of life in patients with moderate-to-severe atopic dermatitis: a real-life 16-week experience
- Resource Type
- article
- Source
- Journal of Dermatological Treatment, Vol 34, Iss 1 (2023)
- Subject
Dermatology RL1-803 - Language
- English
- ISSN
- 0954-6634
1471-1753
09546634